cbdMD, Inc. YCBD
At closeNov 3, 2026, 7:45 PM EST
After hours · Nov 3, 7:45 PM ET
- YTD
- -68.96%
- 1 year
- -50.18%
- Market cap
- 4.69M
- Revenue (ttm)
- 20.64M
- Profit margin
- -94.12%
- EPS (ttm)
- 0.23
- Shares out
- 4.47M
- P/E ratio
- 1.82
- Forward P/E
- -0.38
- YTD return
- -68.96%
- 1-year return
- -50.18%
- Volume
- 273.83K
- Avg volume
- 390.84K
- Open
- 0.391
- Previous close
- 0.3967
- Day's range
- 0.385 – 0.455
- 52-week range
- 0.33 – 2.56
- Beta
- 1.99
- Price target
- 2.00 (+377.3%)
- Earnings date
- Feb 11, 2025
2Y -3.2610 (-88.61%)
Key statistics
- Enterprise value
- 3.22M
- PEG ratio
- 0.00
- Price / sales
- 0.07
- Price / book
- 0.43
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -15.50%
- Free cash flow
- 4.69M
- Total cash
- 2.40M
- Total debt
- 4.11M
- Return on equity
- -135.07%
- Short % of float
- 4.74%
- 50-day average
- 0.46466
- 200-day average
- 0.61418
Analyst view
Next earnings
Feb 11, 2025
Expected Feb 11, 2025. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2025 | Dec 1, 2024 | 0.00 | — | — | — |
| Dec 17, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.15 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -1.35 | — | — |
| Feb 13, 2024 | Dec 1, 2023 | 0.00 | -0.67 | — | — |
| Dec 22, 2023 | Sep 1, 2023 | 0.00 | -9.06 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2023 | Maxim Group | init | — | Buy |
About cbdMD, Inc.
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- cbdmd.com
News
12 Health Care Stocks Moving In Wednesday's After-Market Session 
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
Reserveage Launches Longev+ Exclusively at The Vitamin Shoppe, Bringing Strength Into the Healthy Aging Conversation - 12 Health Care Stocks Moving In Thursday's After-Market Session
cbdMD (NYSEAMERICAN:YCBD) Trading Up 5.1% – What’s Next? 
cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness 
This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday 
cbdMD, Inc. (YCBD) Q3 2026 Earnings Call Transcript - cbdMD Q3 2026 Earnings Call: Complete Transcript
cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026
Your note
Sign in to keep a note on YCBD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| COFFMAN RAYMOND SCOTT | Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jan 10, 2024 | 0 |
| KENNEDY THOMAS RONAN | Chief Executive Officer | Purchase | May 2, 2023 | 6,462 |
| RAINES WILLIAM F III | Director | Stock Award(Grant) | Aug 22, 2024 | 84,256 |
| SELLERS BAKARI T | Director | Stock Award(Grant) | Mar 27, 2024 | 9,438 |
| STEPHEN SCOTT G | Director | Stock Award(Grant) | Mar 27, 2024 | 10,138 |
| SWIFT SIBYL NICHOLE | Director | Stock Award(Grant) | Mar 27, 2024 | 8,008 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Connective Capital Management LLC | 1.61% | 89,215 | 30.53K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.40% | 22,066 | 7.55K | Sep 29, 2024 |
| Vanguard Group Inc | 0.24% | 13,042 | 4.46K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.20% | 11,195 | 3.83K | Sep 29, 2024 |
| Blackrock Inc. | 0.16% | 8,905 | 3.05K | Sep 29, 2024 |
| UBS Group AG | 0.06% | 3,176 | 1.09K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.24% | 13,042 | 4.46K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.16% | 8,992 | 3.08K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.02% | 1,124 | 384 | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.02% | 1,079 | 369 | Oct 30, 2024 |